Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
BioCryst: Q4 Earnings Snapshot
BioCryst: Q4 Earnings Snapshot
Associated Press Finance
Thu, February 26, 2026 at 9:39 PM GMT+9 1 min read
In this article:
BCRX
-0.79%
DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Thursday reported fourth-quarter net income of $245.8 million, after reporting a loss in the same period a year earlier.
The Durham, North Carolina-based company said it had net income of $1.12 per share.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 7 cents per share.
The drugmaker posted revenue of $406.6 million in the period.
For the year, the company reported net income of $263.9 million, or $1.21 per share, swinging to a profit in the period. Revenue was reported as $874.8 million.
BioCryst shares have fallen 3% since the beginning of the year. The stock has dropped nearly 9% in the last 12 months.
This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on BCRX at
Condiciones y Política de privacidad
Privacy Dashboard
More Info